YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor

American Journal of Pathology

Volumn 173, Issue 1, 2008, Pages 130-143

  Bonneh Barkay, Dafna ^a   Bissel, Stephanie J ^a,c   Wang, Gouji ^a   Fish, Kenneth N ^a   Nicholl, Georgina C B ^a   Darko, Samuel W ^a   Medina Flores, Rafael ^a,d   Murphey Corb, Michael ^b   Rajakumar, Premeela A ^b   Nyaundi, Julia ^b   Mellors, John W ^a   Bowser, Robert ^a   Wiley, Clayton A ^a,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BIOLOGICAL MARKER; CHEMOKINE; FIBROBLAST GROWTH FACTOR; PROTEIN; PROTEIN YKL 40;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN TISSUE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; HIPPOCAMPUS; MACACA; MACROPHAGE; MICROGLIA; MITOGENESIS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENCEPHALITIS; VIRUS LOAD;

EID: 46749131543     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080045     Document Type: Article

References (70)

1. Navia BA, Jordan BD, Price RW: The AIDS dementia complex: I. Clinical features. Ann Neurol 1986, 19:517-524
2. Wiley CA, Achim C: Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994, 36:673-676
3. Everall I, Luthert P, Lantos P: A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. J Neuropathol Exp Neurol 1993, 52:561-566
4. Medina-Flores R, Wang G, Bissel SJ, Murphey-Corb M, Wiley CA: Destruction of extracellular matrix proteoglycans is pervasive in simian retroviral neuroinfection. Neurobiol Dis 2004, 16:604-616
5. Fusetti F, Pijning T, Kalk KH, Bos E, Dijkstra BW: Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39. J Biol Chem 2003, 278:37753-37760
6. Bigg HF, Wait R, Rowan AD, Cawston TE: The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation. J Biol Chem 2006, 281:21082-21095
7. Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M: Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res 1997, 237:46-54
8. Rehli M, Niller HH, Ammon C, Langmann S, Schwarzfischer L, Andreesen R, Krause SW: Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. J Biol Chem 2003, 278:44058-44067
9. Recklies AD, White C, Ling H: The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J 2002, 365:119-126
10. Recklies AD, Ling H, White C, Bernier SM: Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes. J Biol Chem 2005, 280:41213-41221
11. Ling H, Recklies AD: The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. Biochem J 2004, 380:651-659
12. Nishikawa KC, Millis AJ: gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res 2003, 287:79-87
13. Zhang JY, Martin LN, Watson EA, Montelaro RC, West M, Epstein L, Murphey-Corb M: Simian immunodeficiency virus/delta-induced immunodeficiency disease in rhesus monkeys: relation of antibody response and antigenemia. J Infect Dis 1988, 158:1277-1286
14. Bissel SJ, Wang G, Ghosh M, Reinhart TA, Capuano III S, Stefano Cole K, Murphey-Corb M, Piatak M Jr, Lifson JD, Wiley CA: Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis. Am J Pathol 2002, 160:927-941
15. Fuller DH, Rajakumar PA, Wilson LA, Trichel AM, Fuller JT, Shipley T, Wu MS, Weis K, Rinaldo CR, Haynes JR, Murphey-Corb M: Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine. J Virol 2002, 76:3309-3317
16. Wiley CA, Soontornniyomkij V, Radhakrishnan L, Masliah E, Mellors J, Hermann SA, Dailey P, Achim CL: Distribution of brain HIV load in AIDS. Brain Pathol 1998, 8:277-284
17. Zhu JH, Kulich SM, Oury TD, Chu CT: Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases. Am J Pathol 2002, 161:2087-2098
18. Repnik U, Knezevic M, Jeras M: Simple and cost-effective isolation of monocytes from buffy coats. J Immunol Methods 2003, 278:283-292
19. Barami K, Grever WE, Diaz FG, Lyman WD: An efficient method for the culturing and generation of neurons and astrocytes from second trimester human central nervous system tissue. Neurol Res 2001, 23:321-326
20. Aridor M, Guzik AK, Bielli A, Fish KN: Endoplasmic reticulum export site formation and function in dendrites. J Neurosci 2004, 24:3770-3776
21. Reinhart TA, Fallert BA, Pfeifer ME, Sanghavi S, Capuano S III, Rajakumar P, Murphey-Corb M, Day R, Fuller CL, Schaefer TM: Increased expression of the inflammatory chemokine CXC chemokine ligand 9/monokine induced by interferon-gamma in lymphoid tissues of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome. Blood 2002, 99:3119-3128
22. Benezra M, Ishai-Michaeli R, Ben-Sasson SA, Vlodavsky I: Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity. J Cell Physiol 2002, 192:276-285
23. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P: Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol 1992, 12:240-247
24. Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM: Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem 2006, 281:15694-15700
25. Ranganathan S, Williams E, Ganchev P, Gopalakrishnan V, Lacomis D, Urbinelli L, Newhall K, Cudkowicz ME, Brown RH Jr, Bowser R: Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem 2005, 95:1461-1471
26. Dumont D, Noben JP, Raus J, Stinissen P, Robben J: Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 2004, 4:2117-2124
27. Choe LH, Dutt MJ, Relkin N, Lee KH: Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease. Electrophoresis 2002, 23:2247-2251
28. Davidsson P, Sjogren M, Andreasen N, Lindbjer M, Nilsson CL, Westman-Brinkmalm A, Blennow K: Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins. Brain Res Mol Brain Res 2002, 109:128-133
29. Tsuji T, Shiozaki A, Kohno R, Yoshizato K, Shimohama S: Proteomic profiling and neurodegeneration in Alzheimer's disease. Neurochem Res 2002, 27:1245-1253
30. Zheng PP, Luider TM, Pieters R, Avezaat CJ, van den Bent MJ, Sillevis Smitt PA, Kros JM: Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors. J Neuropathol Exp Neurol 2003, 62:855-862
31. Luo X, Carlson KA, Wojna V, Mayo R, Biskup TM, Stoner J, Anderson J, Gendelman HE, Melendez LM: Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology 2003, 60:1931-1937
32. Wojna V, Carlson KA, Luo X, Mayo R, Melendez LM, Kraiselburd E, Gendelman HE: Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocyte-derived macrophages: a case study. J Neurovirol 2004, 10(Suppl 1):S74-S81
33. Berger JR, Avison M, Mootoor Y, Beach C: Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: preliminary observations. J Neurovirol 2005, 11:557-562
34. Kronborg G, Ostergaard C, Weis N, Nielsen H, Obel N, Pedersen SS, Price PA, Johansen JS: Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Scand J Infect Dis 2002, 34:323-326
35. Østergaard C, Johansen JS, Benfield T, Price PA, Lundgren JD: YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diagn Lab Immunol 2002, 9:598-604
36. Johansen JS: Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 2006, 53:172-209
37. Powers CJ, McLeskey SW, Wellstein A: Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000, 7:165-197
38. Vaday GG, Lider O: Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J Leukoc Biol 2000, 67:149-159
39. Szebenyi G, Dent EW, Callaway JL, Seys C, Lueth H, Kalil K: Fibroblast growth factor-2 promotes axon branching of cortical neurons by influencing morphology and behavior of the primary growth cone. J Neurosci 2001, 21:3932-3941
40. Katsuki H, Itsukaichi Y, Matsuki N: Distinct signaling pathways involved in multiple effects of basic fibroblast growth factor on cultured rat hippocampal neurons. Brain Res 2000, 885:240-250
41. Morrison RS, Sharma A, de Vellis J, Bradshaw RA: Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc Natl Acad Sci USA 1986, 83:7537-7541
42. Ferrari G, Minozzi MC, Toffano G, Leon A, Skaper SD: Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev Biol 1989, 133:140-147
43. Walicke P, Cowan WM, Ueno N, Baird A, Guillemin R: Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc Natl Acad Sci USA 1986, 83:3012-3016
44. Hatten ME, Lynch M, Rydel RE, Sanchez J, Joseph-Silverstein J, Moscatelli D, Rifkin DB: In vitro neurite extension by granule neurons is dependent upon astroglial-derived fibroblast growth factor. Dev Biol 1988, 125:280-289
45. Zink MC, Suryanarayana K, Mankowski JL, Shen A, Piatak M Jr, Spelman JP, Carter DL, Adams RJ, Lifson JD, Clements JE: High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol 1999, 73:10480-10488
46. Bissel SJ, Wang G, Trichel AM, Murphey-Corb M, Wiley CA: Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected. CD8+ T-cell-depleted macaques that develop lentiviral encephalitis. Am J Pathol 2006, 168:1553-1569
47. Cinque P, Vago L, Ceresa D, Mainini F, Terreni MR, Vagani A, Torri W, Bossolasco S, Lazzarin A: Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. AIDS 1998, 12:389-394
48. Helke KL, Queen SE, Tarwater PM, Turchan-Cholewo J, Nath A, Zink MC, Irani DN, Mankowski JL: 14-3-3 protein in CSF: an early predictor of SIV CNS disease. J Neuropathol Exp Neurol 2005, 64:202-208
49. Towfighi A, Skolasky RL, St Hillaire C, Conant K, McArthur JC: CSF soluble Fas correlates with the severity of HIV-associated dementia. Neurology 2004, 62:654-656
50. Gelbard HA, Nottet HS, Swindells S, Jett M, Dzenko KA, Genis P, White R, Wang L, Choi YB, Zhang D, Lipton SA, Tourtellotte WW, Epstein LG, Gendelman HE: Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 1994, 68:4628-4635
51. Froldi M, Castagna A, Parma M, Piona A, Tedeschi A, Miadonna A, Lorini M, Orazio EN, Lazzarin A: Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement. J Neuroimmunol 1992, 38:155-161
52. Heyes MP, Saito K, Lackner A, Wiley CA, Achim CL, Markey SP: Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB J 1998, 12:881-896
53. Roberts ES, Zandonatti MA, Watry DD, Madden LJ, Henriksen SJ, Taffe MA, Fox HS: Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am J Pathol 2003, 162: 2041-2057
54. Rathcke CN, Vestergaard H: YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 2006, 55:221-227
55. Jensen BV, Johansen JS, Price PA: High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. Clin Cancer Res 2003, 9:4423-4434
56. Cintin C, Johansen JS, Christensen IJ, Price PA, Sorensen S, Nielsen HJ: Serum YKL-40 and colorectal cancer. Br J Cancer 1999, 79:1494-1499
57. Johansen JS, Drivsholm L, Price PA, Christensen IJ: High serum YKL-40 level in patients with small cell lung cancer is related to early death. Lung Cancer 2004, 46:333-340
58. Brasso K, Christensen IJ, Johansen JS, Teisner B, Garnero P, Price PA, Iversen P: Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma. Prostate 2006, 66:503-513
59. Hormigo A, Gu B, Karimi S, Riedel E, Panageas KS, Edgar MA, Tanwar MK, Rao JS, Fleisher M, DeAngelis LM, Holland EC: YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas. Clin Cancer Res 2006, 12:5698-5704
60. Aigner A, Butscheid M, Kunkel P, Krause E, Lamszus K, Wellstein A, Czubayko F: An FGF-binding protein (FGF-BP) exerts its biological function by parallel paracrine stimulation of tumor cell and endothelial cell proliferation through FGF-2 release. Int J Cancer 2001, 92:510-517
61. Vlodavsky I, Korner G, Ishai-Michaeli R, Bashkin P, Bar-Shavit R, Fuks Z: Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 1990, 9:203-226
62. Wu ZL, Zhang L, Yabe T, Kuberan B, Beeler DL, Love A, Rosenberg RD: The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex. J Biol Chem 2003, 278:17121-17129
63. Rifkin DB, Moscatelli D: Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 1989, 109:1-6
64. Ishai-Michaeli R, Eldor A, Vlodavsky I: Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul 1990, 1:833-842
65. Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW: BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 1991, 7:695-702
66. Siegel GJ, Chauhan NB: Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Brain Res Rev 2000, 33:199-227
67. Fischer W, Wictorin K, Bjorklund A, Williams LR, Varon S, Gage FH: Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 1987, 329:65-68
68. Bethel A, Kirsch JR, Koehler RC, Finklestein SP, Traystman RJ: Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats. Stroke 1997, 28:606-615
69. Guo Q, Sebastian L, Sopher BL, Miller MW, Glazner GW, Ware CB, Martin GM, Mattson MP: Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation. Proc Natl Acad Sci USA 1999, 96:4125-4130
70. Tretter YP, Hertel M, Munz B, ten Bruggencate G, Werner S, Alzheimer C: Induction of activin A is essential for the neuroprotective action of basic fibroblast growth factor in vivo. Nat Med 2000, 6:812-815